Get App

Co-Partners

Associate Partners

Close Ad
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
May 20, 16:00
2588.05
-160.05 (-5.82%)
VOLUME 128,336
LIVE
NSE
May 20, 15:59
2589.40
-155.6 (-5.67%)
VOLUME 2,659,265
Download Annual Report PDF Format 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010

Nine Months of Dr Reddys Laboratories

------------------- in Rs. Cr. -------------------
Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Net Sales/Income from operations 7,858.30 6,826.00 7,324.70 7,867.00 7,256.17
Other Operating Income 122.00 41.00 35.00 46.50 66.05
Total Income From Operations 7,980.30 6,867.00 7,359.70 7,913.50 7,322.22
EXPENDITURE
Consumption of Raw Materials 1,579.90 1,437.00 1,434.60 1,560.90 1,850.62
Purchase of Traded Goods 632.10 457.00 502.90 483.70 394.85
Increase/Decrease in Stocks -40.30 -12.70 -167.20 -74.90 -159.03
Power & Fuel -- -- -- -- --
Employees Cost 1,441.90 1,379.70 1,431.00 1,261.20 1,106.53
Depreciation 576.40 584.10 545.50 468.30 353.46
Excise Duty -- -- -- -- --
Admin. And Selling Expenses -- 800.70 759.70 771.70 840.12
R & D Expenses -- -- -- -- --
Provisions And Contingencies -- -- -- -- --
Exp. Capitalised -- -- -- -- --
Other Expenses 2,503.60 1,801.80 1,963.90 1,877.90 1,665.75
P/L Before Other Inc. , Int., Excpt. Items & Tax 1,286.70 419.40 889.30 1,564.70 1,269.92
Other Income 165.70 130.90 533.20 226.30 147.11
P/L Before Int., Excpt. Items & Tax 1,452.40 550.30 1,422.50 1,791.00 1,417.03
Interest 48.10 48.70 41.40 49.50 45.03
P/L Before Exceptional Items & Tax 1,404.30 501.60 1,381.10 1,741.50 1,372.00
Exceptional Items -- -- -- -- --
P/L Before Tax 1,404.30 501.60 1,381.10 1,741.50 1,372.00
Tax 329.80 111.30 220.00 328.50 264.07
P/L After Tax from Ordinary Activities 1,074.50 390.30 1,161.10 1,413.00 1,107.93
Prior Year Adjustments -- -- -- -- --
Extra Ordinary Items -- -- -- -- --
Net Profit/(Loss) For the Period 1,074.50 390.30 1,161.10 1,413.00 1,107.93
Equity Share Capital 83.00 82.90 82.90 85.30 85.18
Reserves Excluding Revaluation Reserves -- -- -- -- --
Equity Dividend Rate (%) -- -- -- -- --
EPS Before Extra Ordinary
Basic EPS 64.75 23.54 69.55 82.86 65.06
Diluted EPS 64.67 23.49 69.38 82.60 64.77
EPS After Extra Ordinary
Basic EPS 64.75 23.54 69.55 82.86 65.06
Diluted EPS 64.67 23.49 69.38 82.60 64.77
Public Share Holding
No Of Shares (Crores) -- -- -- -- 9.73
Share Holding (%) -- -- -- -- 57.11
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- -- -- 4.34
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- 100.00
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- 25.49
Notes
Source : Dion Global Solutions Limited

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for drreddyslaboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.